as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
5.55%
Downside
1.55%
Upside
52 Week's Low
52 Week's High
78.14%
Downside
25.06%
Upside
Check Mbx Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$982.0M
EPS (TTM)
-2.5971
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-56.28%
Compare market cap, revenue, PE, and other key metrics of Mbx Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $982.0M | NA | NA | 0.00% | |
| BUY | $40.4B | 478.23% | -16.34 | -264.83% | |
| BUY | $60.2B | 253.38% | 1425.12 | 1.36% | |
| BUY | $109.1B | 101.56% | 30.31 | 31.86% | |
| BUY | $68.5B | 16.98% | 15.62 | 32.13% |
The Mbx Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mbx Biosciences Inc investment value today
Current value as on today
₹1,03,613
Returns
₹3,613
(+3.61%)
Returns from Mbx Biosciences Inc Stock
Dollar Returns*
₹5,706 (+5.71%)
Search interest for Mbx Biosciences Inc Stock has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, MBX stock has moved up by 28.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 187.3%
| Organisation | Mbx Biosciences Inc |
| Headquarters | 11711 North Meridian Street, Carmel, IN, United States, 46032 |
| CEO | Mr. Peter Kent Hawryluk MBA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Peter Kent Hawryluk MBA | CEO, President & Director |
Mr. Richard B. Bartram CPA | Chief Financial Officer |
Dr. Michael A. Dorato DABT, Ph.D. | Sr. Vice President of Discovery & Non-Clinical Development |
Dr. Chatan Charan Ph.D. | Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls |
Mr. Mark Hope | Senior Vice President of Regulatory & Quality |
Dr. Salomon Azoulay M.D. | Chief Medical Officer |
Mr. Matt Gambino | Vice President of Marketing |
Ms. Michelle Graham | Chief Human Resources Officer |
Dr. Andreas Moraitis M.D. | Senior Vice President of Clinical Development |
Mbx Biosciences Inc share price today is $21.99 as on at the close of the market. Mbx Biosciences Inc share today touched a day high of $22.33 and a low of $20.77.
Mbx Biosciences Inc share touched a 52 week high of $27.5 on and a 52 week low of $4.81 on . Mbx Biosciences Inc stock price today i.e. is closed at $21.99,which is 20.04% down from its 52 week high and 357.47% up from its 52 week low.
Mbx Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Mbx Biosciences Inc (MBX) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Mbx Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mbx Biosciences Inc share’s latest price of $21.99 as on November 1, 2025 at 1:29 am IST, you will get 0.4548 shares of Mbx Biosciences Inc. Learn more about
fractional shares .